Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Features Archive

  • Featured Story

    Biotech Goes Wild

    Genetic engineering will be essential to feed the world’s billions. But could it unleash a race of “superweeds”? No one seems to know. And nobody’s in charge of finding out.

  • Featured Story

    A Nose for Business

    What’s the difference between Chanel No. 5 and Chanel No. 19? Ask Cyranose 2000, an artificial proboscis that’s sniffing out the market.

  • Featured Story

    Into the Big Blue Yonder

    A few years ago, IBM’s vaunted Research division went through a stormy upheaval. But the labs have bounced back, and the future looks bright.

  • Featured Story

    Dances with Machines

    Artist David Rokeby builds machines that watch us, make music with us, speak to us and free-associate on our behalf.

  • Featured Story

    CPR for the Artificial Heart

    Reviled in the ’80s and forgotten in the ’90s, the artificial heart is back and beating. TR readers get a rare glimpse inside the company that’s developing it.

  • Featured Story

    Titans Talk Tech

    Michael Dertouzos and Bill Gates ponder open-source software and the future of the computing industry.

  • Featured Story

    Cyborg Seeks Community

    Meet one of the creators of wearable computing and join him in his search for like-minded folks to live in an augmented reality.

  • Featured Story

    Fountain of Ideas

    A reservoir for computing innovation, LCS has provided a haven for startups-and a place for researcher/entrepreneurs to regroup and begin again.

  • Featured Story

    Seeing Is Believing

    There’s a ways to go yet, but the artificial retina is poised to move out of academic labs and into corporate R&D.

Pages

From the Archives